EPO-derived tissue protection
Also known as: ARA 290 · Cibinetide · pHBSP
The essentials at a glance
Studied clinically for inflammatory, nerve and metabolic outcomes; it lacks general medicinal approval.
Distinction: ARA-290 is derived from erythropoietin but acts without its blood-forming effect, unlike classic EPO products.
Prohibited or covered under WADA rules in competitive sport.
The substance is currently being studied in structured human clinical trials, but a general approval does not yet exist.
In clinical research: A clinical-development candidate, not an approved medicinal product.
Research questions
This studies whether a fragment derived from erythropoietin can convey tissue protection without the blood-forming activity of the original hormone, similar to a piece that retains only one of several functions. Cell survival and inflammation markers are measured in lab models.
This examines whether a substance can protect nerve cells from stress or damage, such as after oxygen deprivation in a cell model. Cell survival and signalling markers in nerve tissue under lab conditions are measured.
This studies how a peptide adjusts immune cell activity, similar to a dial that strengthens or dampens the immune response. Immune cell counts and inflammation markers are measured in studies.
Simple example
Think of it like a component still being tested in a development workshop, not yet cleared for general use.
Research status means efficacy, dosing, and safety in humans are not yet conclusively established.
Community themes
Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.
Personal recovery times after sports injuries while using different repair peptides are compared, often based on subjective pain scales. Such individual courses are influenced by many other factors and do not prove efficacy.
Users compare self-assembled combinations of peptides aimed at influencing ageing processes or energy levels, often based on blood tests or subjective wellbeing scales. Personal self-experiments and marketing promises do not replace controlled long-term human studies.
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
Why individual profiles do not contain mixing instructions
Reconstitution depends on the exact product, label, identity, concentration, sterility and stability. Arithmetic examples appear only in the separately labelled community area and are not recommendations.
Reconstitution & quantitiesOpen basics, units and sourcesUse & mixingEvidence boundary
General medicinal approval is lacking despite clinical study.
No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.
Primary sources
Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.
